Skip to main content
Clinical Trials/ISRCTN99373118
ISRCTN99373118
Completed
未知

Investigating transcutaneous neuromodulation for reduction of bladder, bowel and spasticity in spinal cord injury as an alternative to pharmacological treatment: towards wearable devices

Royal National Orthopaedic Hospital NHS Trust0 sites10 target enrollmentJuly 7, 2017

Overview

Phase
未知
Intervention
Not specified
Conditions
Specialty: Renal disorders, Primary sub-specialty: Renal disorders
Sponsor
Royal National Orthopaedic Hospital NHS Trust
Enrollment
10
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

Registry
who.int
Start Date
July 7, 2017
End Date
September 13, 2019
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Royal National Orthopaedic Hospital NHS Trust

Eligibility Criteria

Inclusion Criteria

  • 1\. Spinal Cord Injured
  • 2\. Aged 18\-70
  • 3\. Male or Female
  • 4\. Injury sustained \>6 months ago
  • 5\. Urodynamically proven Neurogenic Detrusor Overactivity

Exclusion Criteria

  • 1\. Recipient of intra\-detrusor botulinum toxin injections within the last 6 months
  • 2\. Previous surgical intervention on bladder/sphincters
  • 3\. Showing positive leucocytes and nitrites on urinalysis on the day of investigation
  • 4\. Pregnancy

Outcomes

Primary Outcomes

Not specified

Similar Trials